Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 19529750)

1.

Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.

Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, González-García M, Moltó J, Negredo E, Clotet B.

AIDS Rev. 2009 Apr-Jun;11(2):103-9. Review.

PMID:
19529750
2.

Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment.

Mothapo KM, Schellekens A, Crevel Rv, Keuter M, Grintjes-Huisman K, Koopmans P, der Ven Av.

CNS Neurol Disord Drug Targets. 2015;14(6):811-8.

PMID:
25808896
3.

Ginkgo biloba: reduced efficacy of efavirenz.

[No authors listed]

Prescrire Int. 2015 Jan;24(156):21. No abstract available.

PMID:
25729835
4.

The challenge of paediatric efavirenz dosing: implications and way forward for the sub-Saharan Africa.

Mukonzo JK.

AIDS. 2014 Aug 24;28(13):1855-7. doi: 10.1097/QAD.0000000000000372. No abstract available.

PMID:
25259700
5.

[Acute psychosis as a side effect of efavirenz therapy with metabolic anomalies: an important differential diagnosis of HIV-associated psychoses].

Hinsch MC, Reichelt D, Husstedt IW.

Nervenarzt. 2014 Oct;85(10):1304-8. doi: 10.1007/s00115-014-4157-9. German.

PMID:
25200885
6.

Efavirenz modulation of sleep spindles and sleep spectral profile.

Simen AA, Ma J, Svetnik V, Mayleben D, Maynard J, Roth A, Mixson L, Mogg R, Shera D, George L, Mast TC, Beals C, Stoch A, Struyk A, Shire N, Fraser I.

J Sleep Res. 2015 Feb;24(1):66-73. doi: 10.1111/jsr.12196. Epub 2014 Aug 12.

PMID:
25113527
7.

Summaries for patients. Efavirenz and the risk for suicidal behaviors.

[No authors listed]

Ann Intern Med. 2014 Jul 1;161(1):I-14. doi: 10.7326/P14-9019. No abstract available.

PMID:
24979460
8.

Interleukin-10 gene polymorphism (-1082G/A) and allergy to efavirenz in patients infected with human immunodeficiency virus.

Rodrigues Rde O, Carvalho PG, Arruda EA, Rabenhorst SH, Silva SF, Ribeiro IF, Lima DG, Nagao-Dias AT.

Braz J Infect Dis. 2014 Jul-Aug;18(4):445-8. doi: 10.1016/j.bjid.2014.01.009. Epub 2014 May 10.

9.

Baseline predictors of efavirenz-containing antiretroviral regimen adverse experiences.

Sonenthal PD, Ratshaa B, Chimbengo G, Rantleru T, Ngoni T, Barenbaum S, Platoff R, Steenhoff AP, Gross R.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):773-7. doi: 10.1002/pds.3615. Epub 2014 Mar 24.

PMID:
24664872
10.

Has the time come to abandon efavirenz for first-line antiretroviral therapy?

Raffi F, Pozniak AL, Wainberg MA.

J Antimicrob Chemother. 2014 Jul;69(7):1742-7. doi: 10.1093/jac/dku058. Epub 2014 Mar 5. Review.

PMID:
24603962
11.

Encephalocele following a periconceptional exposure to efavirenz: a case report.

Gudu W, Bekele D.

J Perinatol. 2013 Dec;33(12):987-8. doi: 10.1038/jp.2013.121.

PMID:
24276177
12.

Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events.

Ibarra-Barrueta O, Palacios-Zabalza I, Mora-Atorrasagasti O, Mayo-Suarez J.

Ann Pharmacother. 2014 Jan;48(1):145-8. doi: 10.1177/1060028013510396. Epub 2013 Nov 5.

PMID:
24259633
13.

Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.

Gutiérrez F, García L, Padilla S, Alvarez D, Moreno S, Navarro G, Gómez-Sirvent J, Vidal F, Asensi V, Masiá M; CoRIS.

HIV Med. 2014 Apr;15(4):213-23. doi: 10.1111/hiv.12104. Epub 2013 Nov 11.

PMID:
24215356
14.
15.

Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.

van Ramshorst MS, Kekana M, Struthers HE, McIntyre JA, Peters RP.

BMC Pediatr. 2013 Aug 13;13:120. doi: 10.1186/1471-2431-13-120.

16.

Neuronal toxicity of efavirenz: a systematic review.

Decloedt EH, Maartens G.

Expert Opin Drug Saf. 2013 Nov;12(6):841-6. doi: 10.1517/14740338.2013.823396. Epub 2013 Jul 29. Review.

PMID:
23889591
17.

[Changes in driving skills in patients who start treatment with efavirenz].

Poquet I, Bourguet M, Cioaia S, Tornero C.

Enferm Infecc Microbiol Clin. 2014 Jan;32(1):59-60. doi: 10.1016/j.eimc.2013.05.008. Epub 2013 Jul 17. Spanish. No abstract available.

PMID:
23871096
18.

Treatment. Least virological failure in children taking efavirenz.

[No authors listed]

AIDS Policy Law. 2013 Jun;28(7):1. No abstract available.

PMID:
23855049
19.

Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases.

Isaacs T, Ngwanya MR, Dlamini S, Lehloenya RJ.

J Antimicrob Chemother. 2013 Dec;68(12):2871-4. doi: 10.1093/jac/dkt287. Epub 2013 Jul 12.

20.

Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.

Elsharkawy AM, Schwab U, McCarron B, Burt AD, Daly AK, Hudson M, Masson S.

J Clin Virol. 2013 Sep;58(1):331-3. doi: 10.1016/j.jcv.2013.05.003. Epub 2013 Jun 12.

PMID:
23763943
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk